4//SEC Filing
DEMANE MICHAEL F 4
Accession 0001567619-22-018224
CIK 0001444380other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 5:51 PM ET
Size
8.7 KB
Accession
0001567619-22-018224
Insider Transaction Report
Form 4
NEVRO CORPNVRO
DEMANE MICHAEL F
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2022-09-30+563→ 19,339 total
Holdings
- 49,911(indirect: See footnote)
Common Stock
- 59,580(indirect: See footnote)
Common Stock
- 164,344(indirect: See footnote)
Common Stock
- 82,541(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]Fully vested restricted stock. The restricted stock represent quarterly retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.
- [F2]Includes 4,155 restricted stock units. Reflects the transfer of 10,555 directly held shares to the SLAT Trust and 15,569 directly held shares to the 2012 Trust, on January 13, 2022.
- [F3]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012 (the "2012 Trust").
- [F4]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017 (the "SLAT Trust").
- [F5]Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011 (the "2011 Trust"). Reflects the transfer of 47,980 shares previously held by Michael F. DeMane 2021 Retained Annuity Trust U/A 04/23/2021 to the 2011 Trust on September 14, 2022.
- [F6]Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.
Documents
Issuer
NEVRO CORP
CIK 0001444380
Entity typeother
Related Parties
1- filerCIK 0001174533
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 5:51 PM ET
- Size
- 8.7 KB